Influenza vaccine effectiveness in households with children during the 2012-2013 season: Assessments of prior vaccination and serologic susceptibility

Journal of Infectious Diseases

Volumn 211, Issue 10, 2015, Pages 1519-1528

  Ohmit, Suzanne E ^a   Petrie, Joshua G ^a   Malosh, Ryan E ^a   Fry, Alicia M ^b   Thompson, Mark G ^b   Monto, Arnold S ^a  

^a UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Households with children; Influenza; Serologic susceptibility; Vaccine effectiveness

Indexed keywords

INFLUENZA VACCINE; VIRUS ANTIBODY;

ACUTE RESPIRATORY TRACT DISEASE; ADOLESCENT; ADULT; AGE; ANTIBODY TITER; ARTICLE; CHILD; DRUG EFFICACY; FEMALE; HEMAGGLUTINATION INHIBITION TEST; HOUSEHOLD; HUMAN; INFECTION SENSITIVITY; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS B; MALE; PRIORITY JOURNAL; BLOOD; FAMILY SIZE; IMMUNOLOGY; INFANT; INFLUENZA, HUMAN; MIDDLE AGED; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; CHILD; FAMILY CHARACTERISTICS; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84929658254     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu650     Document Type: Article

References (27)

1. Osterholm MT, Kelley NS, Sommer A, Belongia A. Efficacy and effectiveness of influenza vaccines: A systematic review and meta-analysis. Lancet Infect Dis 2012; 12:36-44.
2. Foppa IM, Haber M, Ferdinands JM, et al. The case test-negative design for studies of the effectiveness of influenza vaccine. Vaccine 2013; 31: 3104-9.
3. Jackson ML, Nelson JC. The test-negative design for estimating influenza vaccine effectiveness. Vaccine 2013; 19:2165-8.
4. Griffin MR, Monto AS, Belongia EA, et al. Effectiveness of nonadjuvanted pandemic influenza A vaccines for preventing pandemic influenza acute respiratory illness visits in 4 U.S. communities. PLoS One 2011; 6:e23085.
5. Treanor J, Talbot HK, Ohmit SE, et al. Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains. Clin Infect Dis 2012; 55:951-9.
6. Ohmit SE, ThompsonMG, Petrie JG, et al. Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clin Infect Dis 2014; 58:319-27.
7. Kissling E, Valenciano M, Larrauri A, et al. Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multi-centre case control study. Euro Surveill 2013; 18:pii:20390.
8. Fielding JE, Grant KA, Tran T, Kelly HA. Moderate influenza vaccine effectiveness in Victoria, Australia, 2011. Euro Surveill 2012; 17:11.
9. Skowronski DM, Janjua NZ, De Serres G, et al. A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011. Clin Infect Dis 2012; 55:333-42.
10. Ohmit SE, Petrie JG, Malosh RE, et al. Influenza vaccine effectiveness in the community and the household. Clin Infect Dis 2013; 56:1363-9.
11. CDC FluView. 2012-2013 influenza season surveillance summary. http://www.cdc.gov/flu/weekly/pdf/12-13%20Season%20Summary.pdf. Accessed 4 December 2014.
12. de Jong JC, Palache AM, Beyer WEP, Rimmelzwaan GF, Boon ACM, Osterhaus ADME. Haemagglutination-inhibiting antibody to influenza virus. In: Brown F, Haaheim LR, Schild GC, eds. Laboratory correlates of immunity to influenza-a reassessment. Basel, Switzerland: Karger, 2003:63-73.
13. Ohmit SE, Petrie JG, Cross RT, Johnson E, Monto AS. Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection. J Infect Dis 2011; 204:1879-85.
14. WHO. Recommended composition of influenza virus vaccines for use in the 2012-2013 northern hemisphere influenza season. Weekly Epidemiologic Report 2012; 87:83-96.
15. Lambre CR, Terzidis H, Greffard A,Webster RG. Measurement of antiinfluenza neuraminidase antibody using a peroxidase-linked lectin and microtitre plates coated with natural substrates. J Immunol Methods 1990; 135:49-57.
16. Cate TR, Rayford Y, Nino D, et al. A high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjects. Vaccine 2010; 28:2076-9.
17. Fiore AE, Uyeki TM, Broder K, et al. Prevention and control of influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 2010;55 (RR-08):1-62.
18. Wei LJ, Lin DY, Weissfeld L. Regression analysis of multivariate incomplete failure time data by modeling marginal distribution. J Am Statistical Assoc 1989; 84:1065-73.
19. Sullivan SG, Kelly H. Stratified estimates of influenza vaccine effectiveness by prior vaccination: caution required [correspondence]. Clin Infect Dis 2013; 57:474-6.
20. CDC. Prevention and control of influenza with vaccines: recommendations of the advisory committee on immunization practices (ACIP)-United States, 2012-13 influenza season. MMWR Morb Mortal Wkly Rep 2012; 61:613-8.
21. Beyer WE, de Bruijn IA, Palache AM, Westerdorp RG, Osterhaus AD. Protection against influenza after annually repeated vaccination; a metanalysis of serologic and field studies. Arch Intern Med 1999; 159:182-8.
22. Sasaki S, He XS, Holmes TH, et al. Influence of prior influenza vaccination on antibody and B-cell responses. PLoS One 2008; 3:e2975.
23. Smith DJ, Forrest S, Ackley DH, Perelson AS. Variable efficacy of repeated annual influenza vaccination. Proc Natl Acad Sci 1999; 96:14001-6.
24. Smith DJ, Lapedes AS, Forrest S, et al. Modeling the effects of updating the influenza vaccine on the efficacy of repeated vaccination. In: Osterhaus ADME, Cox N, Hampson A, eds. Options for the control of influenza virus IV. International Congress Series 1219. Amsterdam: Excerpta Medica, 2001:655-60.
25. Vesikari T, Knuf M, Wutzler P, et al. Oil-in-Water emulsion adjuvant with influenza vaccine in young children. N Engl J Med 2011; 365: 1406-16.
26. Jackson L, Jackson ML, Phillips CH, et al. Interim adjusted estimates of seasonal influenza vaccine effectiveness-United States, February 2013. MMWR Morb Mortal Wkly Rep 2013; 62:119-23.
27. Jain VK, Rivera L, Zaman K, et al. Vaccine for prevention of mild and moderate-to-severe influenza in children. N Engl J Med 2013; 369: 2481-91.